Your Health, We Care

Home >Drug List>Pomalidomide>Indications of Pomalidomide

Pomalidomide(LuciPoma)

Release date: 2026-10-21 15:12:12     Recommended: 2

Indicated for adults with relapsed/refractory multiple myeloma who progressed on or within 60 days of $\ge$2 prior therapies (including lenalidomide and a PI).